²é¿´: 1168  |  »Ø¸´: 4

³ÕÃÎäìÏæ

ľ³æ (ÖøÃûдÊÖ)


[½»Á÷] ¿¹°¬Ò©£ºTivicay (dolutegravir)Ƭ£¨2013-08-12£© ÒÑÓÐ4È˲ÎÓë

ÉÌÆ·Ãû£ºTivicay  Í¨ÓÃÃû£ºdolutegravir  ÖÐÎÄÃû£ºÎ´Öª
ÉóÅú·ÖÀࣺÓÅÏÈÉóÆÀ
Ò©Æó£ºGlaxoSmithKline

ÊÊÓ¦Ö¢£ºHIV-1¸ÐȾ¡£12ËêÒÔÏ»òÌåÖØÔÚ40kgÒÔϵĶùͯ²»ÍƼöʹÓá£

¼ÁÐ͹æ¸ñ£º±¾Æ·ÎªÆ¬¼Á£¬50mg/Ƭ£¬50-100mg/Ìì¡£
  
»îÐԳɷ֣ºdolutegravirÄÆÑΣ¬½á¹¹Ê½ÈçÏ£º
¿¹°¬Ò©£ºTivicay (dolutegravir)Ƭ£¨2013-08-12£©

×÷ÓûúÀí£ºdolutegravirÊÇHIVÕûºÏøÒÖÖÆ¼Á£¬×èÖ¹²¡¶¾DNAÁ´ÏòËÞÖ÷DNA×ªÒÆ¡£

ÁÙ´²ÊÔÑ飺
ÔÚSPRING-2ÁÙ´²ÊÔÑéÖУ¬822Àýδ¾­ÖÎÁƵϼÕßËæ»ú·Ö³ÉTivicay+Epzicom/Truvada×é¡¢raltegravir+Epzicom/Truvada×飬ÒÔ48ÖÜʱHIV-1 RNA <50 copies/mLΪÁÙ´²Öյ㣬Tivicay+Epzicom/Truvada×éÂÔÓÅÓÚraltegravir+Epzicom/Truvada×飨88% vs 86%£©¡£
ÔÚSINGLEÁÙ´²ÊÔÑéÖУ¬833Àýδ¾­ÖÎÁƵϼÕßËæ»ú·Ö³ÉTivicay+Epzicom×é¡¢Atripla×飬ÒÔ48ÖÜʱHIV-1 RNA <50 copies/mLΪÁÙ´²Öյ㣬Tivicay+Epzicom×éÓÅÓÚAtripla×飨88% vs 81%£©¡£
ÔÚSAILINGÁÙ´²ÊÔÑéÖУ¬719ÀýÓп¹Äæ×ªÂ¼ÖÎÁƾ­Àúµ«Î´Ê¹ÓÃÕûºÏøÒÖÖÆ¼ÁµÄ»¼ÕßËæ»ú·Ö³ÉTivicay+»ù´¡ÖÎÁÆ×é¡¢raltegravir+»ù´¡ÖÎÁÆ×飬ÒÔ24ÖÜʱHIV-1 RNA <50 copies/mLΪÁÙ´²Öյ㣬Tivicay×éÓÅÓÚraltegravir×飨79% vs 70%£©¡£
ÔÚVIKING-3ÁÙ´²ÊÔÑéÖУ¬183ÀýraltegravirºÍ/»òelvitegravirÄÍÒ©ÐÍ»¼Õߣ¬¾­Tivicay+»ù´¡ÖÎÁÆ24ÖÜʱHIV-1 RNA <50 copies/mL´ï³ÉÂÊΪ63%¡£
ÔÚIMPAACT P1093ÁÙ´²ÊÔÑéÖУ¬23Àý12-17ËêµÄÇàÉÙÄ껼Õߣ¬¾­Tivicay+»ù´¡ÖÎÁÆÖÎÁÆ24ÖÜʱHIV-1 RNA <50 copies/mL´ï³ÉÂÊΪ70%¡£

²»Á¼·´Ó¦£ºÊ§Ãß¡¢Í·Í´¡¢¹ýÃô¡¢¸Î¹¦ÄÜÒì³£¡£

Ïà¹Ø×¨Àû£ºWO2006116764A1£¨»¯ºÏÎ£»WO2010068262A1£¨¹¤ÒÕ£©£»WO2010011819A1£¨Ç°Ò©£©£»WO2010068253A1£¨¹¤ÒÕ£©£»WO2010067176A1£¨ÖмäÌ幤ÒÕ£©£»WO2011119566A1£¨¹¤ÒÕ£©£»WO2012018065A1£¨¹¤ÒÕ£©¡£

ºÏ³É×ÛÊö£ºDrugs Fut, 2012, 37(10), 697.
¹¹Ð§¹ØÏµ£ºJ Med Chem. 2013, 56, 5901-5916.

²¹³ä˵Ã÷£ºTivicayÊÇGSK½ñÄêÉÏÊеĵÚ4¸öÐÂÒ©£¬Ô¤¼Æ2020ÄêÏúÊÛ¶î16.2ÒÚÃÀÔª¡£ÒÑÉÏÊеÄHIVÕûºÏøÒÖÖÆ¼ÁÓÐÀ×ÌØ¸ñΤ(raltegravir)¡¢°£Ìæ¸ñΤ(elvitegravir)¡£

[ Last edited by ³ÕÃÎäìÏæ on 2013-8-13 at 20:07 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

fw8505

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
¼òµ¥¹Ø×¢Ò»ÏÂÕâ¸öÁìÓò
2Â¥2013-08-13 16:23:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
3Â¥2013-08-14 10:54:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ã÷Ô·ɹâ

Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)

À´Ñ§Ï°Ò»ÏÂ
4Â¥2013-08-14 10:57:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÕŵÂÌÎ

ľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
¸ÃÒ©ÔÚË®ÖеÄÈܽâ¶ÈÈçºÎ°¡£¬µ±µ½´ïθ²¿Ê±Èܽâ¶ÈÊÇÔõô±ä»¯µÄ°¡¡­¡­
5Â¥2015-01-07 16:13:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ³ÕÃÎäìÏæ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 292Çóµ÷¼Á +9 ¶ì¶ì¶ì¶î¶î¶î¶î¶ 2026-03-25 10/500 2026-03-26 16:27 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 289Çóµ÷¼Á +17 ˶ÐǸ° 2026-03-23 17/850 2026-03-26 16:18 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ×ÊÔ´Óë»·¾³ µ÷¼ÁÉêÇë(333·Ö) +9 holy J 2026-03-21 9/450 2026-03-26 15:47 by 161765490
[¿¼ÑÐ] 0703»¯Ñ§/290Çóµ÷¼Á/±¾¿Æ¾­Àú·á¸»/¹¤¿ÆÒ²¿É +6 µ¤ÇàÄÌ¸Ç 2026-03-26 6/300 2026-03-26 15:04 by anny19840123
[¿¼ÑÐ] ²ÄÁÏѧ˶297ÒѹýËÄÁù¼¶Çóµ÷¼ÁÍÆ¼ö +13 adaie 2026-03-19 13/650 2026-03-26 14:05 by ССÂóƬ
[¿¼ÑÐ] 274Çóµ÷¼Á +13 ¹Ë¾ÅóÏҪǫÐé 2026-03-24 19/950 2026-03-26 13:30 by ССÂóƬ
[¿¼ÑÐ] 303Çóµ÷¼Á +6 À¶É½Ô 2026-03-25 6/300 2026-03-25 22:47 by 418490947
[¿¼ÑÐ] Çóµ÷¼Á +3 QiMing7 2026-03-25 3/150 2026-03-25 21:13 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] ²ÄÁÏר˶ 335 ·ÖÇóµ÷¼Á +4 ¾Ü¾øÀ䱩Á¦ 2026-03-25 4/200 2026-03-25 18:45 by haxia
[¿¼ÑÐ] 296Çóµ÷¼Á +4 Íô£¡£¿£¡ 2026-03-25 7/350 2026-03-25 16:41 by Íô£¡£¿£¡
[¿¼ÑÐ] 284Çóµ÷¼Á +15 Zhao anqi 2026-03-22 15/750 2026-03-25 12:51 by wht0531
[¿¼ÑÐ] 285Çóµ÷¼Á +3 AZMK 2026-03-24 3/150 2026-03-25 12:23 by userper
[¿¼ÑÐ] ²ÄÁÏѧ˶£¬Çóµ÷¼Á 6+4 ÌǺù«888ll 2026-03-22 9/450 2026-03-25 11:19 by greychen00
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +6 ÄÌÓͲÝÝ®. 2026-03-22 7/350 2026-03-25 10:00 by shangxh
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯315 Çóµ÷¼Á +3 akrrain 2026-03-24 3/150 2026-03-24 19:35 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] ²ÄÁÏר˶331Çóµ÷¼Á +4 Ïʵ±Å£ 2026-03-24 4/200 2026-03-24 15:58 by JourneyLucky
[¿¼ÑÐ] 291Çóµ÷¼Á +8 hhhhxn.. 2026-03-23 8/400 2026-03-23 23:15 by peike
[¿¼ÑÐ] 298Çóµ÷¼ÁÒ»Ö¾Ô¸211 +3 Éϰ¶6666@ 2026-03-20 3/150 2026-03-22 15:50 by ColorlessPI
[¿¼ÑÐ] 303Çóµ÷¼Á +5 °²ÒäÁé 2026-03-22 6/300 2026-03-22 12:46 by ËØÑÕÇã³Ç1988
[¿¼ÑÐ] Çóµ÷¼Á +4 ÒªºÃºÃÎÞÁÄ 2026-03-21 4/200 2026-03-21 18:57 by ѧԱ8dgXkO
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û